首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1542532

全球 HLA 打字市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global HLA Typing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到 2032 年，全球 HLA 分型市场的市场规模将从 2023 年的 575 万美元达到近 1,411 万美元，2024-2032 年研究期间复合年增长率为 10.5%。

HLA 分型或人类白血球抗原分型是一种用于识别细胞表面特定蛋白质的过程，这些蛋白质对于免疫系统识别外来物质的能力至关重要。这些蛋白质由主要组织相容性复合体 (MHC) 内的基因编码，帮助免疫系统区分自身细胞和非自身细胞。它在包括器官移植在内的各种医疗环境中都很重要，其中匹配捐赠者和接受者的 HLA 图谱可以降低排斥风险。它也用于输血和疾病关联研究，有助于自体免疫疾病和某些癌症的诊断和治疗。

市场动态

HLA 分型市场正在受到塑造医学诊断和移植医学格局的几个关键因素的推动。自体免疫疾病、传染病和血液恶性肿瘤的盛行率不断增加，需要准确可靠的 HLA 分型来进行疾病诊断、预后和治疗选择。此外，由于人口老化和慢性病的流行，对器官和组织移植的需求不断增长，这也加剧了对器官和组织移植过程的需求，以匹配捐赠者和受者并最大限度地降低排斥风险。此外，NGS、聚合酶炼式反应和序列特异性寡核苷酸探针(SSOP) 等HLA 分型技术的进步提高了这些检测的准确性、速度和可扩展性，从而实现了高分辨率分型和等位基因识别。此外，在临床指南和监管标准的支持下，它融入常规临床实践和移植管理协议，推动了打字服务在全球医疗保健机构中的采用和利用。此外，增加研发投资以扩大其在个人化医疗、药物基因组学和免疫分析方面的应用，有助于该技术和服务的市场成长和创新。此外，医疗保健组织、诊断实验室和技术提供者之间的策略合作和伙伴关係促进了新型 HLA 分型解决方案的开发和商业化，并扩大了市场范围。然而，严格的监管要求和程序的复杂性可能会阻碍该市场未来几年的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球 HLA 分型市场的各个细分市场进行了包容性评估。 HLA 分型产业的成长和趋势为本研究提供了整体方法。

市场区隔

HLA 打字市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

仪器仪表
试剂及耗材
软体与服务

按申请

诊断
研究

依技术

分子检测
基于定序的分子测定
非分子检测

按最终用户

商业服务提供者
医院及移植中心
研究实验室和学术机构

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的 HLA 分型市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 HLA 分型市场的主要参与者包括 Thermo Fisher Scientific Inc.、Bio-Rad Laboratories Inc.、Qiagen NV、Omixon Inc.、GenDx、Illumina Inc.、TBG Diagnostics Limited、Dickinson and Company、Takara Bio Inc.、F.霍夫曼-拉罗氏有限公司、太平洋生物科学公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按产品分類的市场吸引力分析
- 市场吸引力分析：依应用分类
- 按技术分類的市场吸引力分析
- 最终用户的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球 HLA 分型市场分析：依产品

按产品概述
历史和预测数据
按产品分析
仪器仪表
试剂及耗材
软体与服务

第 6 章：全球 HLA 分型市场分析：依应用分类

概述：按应用
历史和预测数据
分析：按应用
诊断
研究

第 7 章：全球 HLA 分型市场分析：依技术分类

依技术概述
历史和预测数据
技术分析
分子检测
基于定序的分子测定
非分子检测

第 8 章：全球 HLA 分型市场分析：依最终使用者分类

最终用户概述
历史和预测数据
最终用户分析
商业服务提供者
医院及移植中心
研究实验室和学术机构

第 9 章：全球 HLA 分型市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：HLA 打字公司的竞争格局

Hla 打字市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

公司股份分析
市场集中度
Thermo Fisher Scientific Inc.

公司概况
公司收入
产品
最新动态

Bio-Rad Laboratories Inc.

公司概况
公司收入
产品
最新动态

Qiagen NV

公司概况
公司收入
产品
最新动态

Omixon Inc.

公司概况
公司收入
产品
最新动态

GenDx

公司概况
公司收入
产品
最新动态

Illumina Inc.

公司概况
公司收入
产品
最新动态

TBG Diagnostics Limited

公司概况
公司收入
产品
最新动态

Dickinson and Company

公司概况
公司收入
产品
最新动态

Takara Bio Inc.

公司概况
公司收入
产品
最新动态

F. Hoffman-La Roche Limited

公司概况
公司收入
产品
最新动态

Pacific Biosciences

公司概况
公司收入
产品
最新动态

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112110056

The global demand for HLA Typing Market is presumed to reach the market size of nearly USD 14.11 Million by 2032 from USD 5.75 Million in 2023 with a CAGR of 10.5% under the study period 2024 - 2032.

HLA typing, or human leukocyte antigen typing, is a process used to identify specific proteins on the surface of cells that are crucial in the immune system's ability to recognize foreign substances. These proteins, encoded by genes within the major histocompatibility complex (MHC), help the immune system distinguish between self and non-self cells. It is important in various medical contexts, including organ transplantation, where matching the HLA profiles of donors and recipients reduces rejection risks. It is also used in blood transfusions and disease association studies, aiding in the diagnosis and treatment of autoimmune diseases and certain cancers.

MARKET DYNAMICS

The HLA typing market is being propelled by several key factors shaping the landscape of medical diagnostics and transplantation medicine. The increasing prevalence of autoimmune diseases, infectious diseases, and hematological malignancies necessitates accurate and reliable HLA typing for disease diagnosis, prognosis, and treatment selection. Additionally, the rising demand for organ and tissue transplantation, driven by the growing aging population and the prevalence of chronic diseases, fuels the need for this process to match donors and recipients and minimize the risk of rejection. Moreover, advancements in HLA typing technologies, such as NGS, polymerase chain reaction, and sequence-specific oligonucleotide probes (SSOP), enhance the accuracy, speed, and scalability of these assays, enabling high-resolution typing and allele identification. Furthermore, its integration into routine clinical practice and transplant management protocols, supported by clinical guidelines and regulatory standards, drives the adoption and utilization of typing services in healthcare settings worldwide. Additionally, increasing investments in research and development to expand its applications in personalized medicine, pharmacogenomics, and immune profiling contribute to market growth and innovation in this technology and service. Furthermore, strategic collaborations and partnerships among healthcare organizations, diagnostic laboratories, and technology providers facilitate the development and commercialization of novel HLA typing solutions and expand market reach. However, stringent regulatory requirements and the complexity of the procedures may hinder the growth of this market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain Analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of HLA typing. The growth and trends of HLA typing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the hla typing market report provides detailed data on the segments at the country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments
Reagents & Consumables
Software & Services

By Application

Diagnosis
Research

By Technique

Molecular Assay
Sequenced-Based Molecular Assay
Non-Molecular Assay

By End-User

Commercial Service Providers
Hospitals And Transplant Centers
Research Labs & Academic Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the HLA Typing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the HLA typing market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc., F. Hoffman-La Roche Limited, Pacific Biosciences. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . HLA TYPING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Technique
- 3.7.4 Market Attractiveness Analysis By End-User
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL HLA TYPING MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Instruments Historic and Forecast Sales by Regions
5.5 Reagents & Consumables Historic and Forecast Sales by Regions
5.6 Software & Services Historic and Forecast Sales by Regions

6 . GLOBAL HLA TYPING MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Diagnosis Historic and Forecast Sales by Regions
6.5 Research Historic and Forecast Sales by Regions

7 . GLOBAL HLA TYPING MARKET ANALYSIS BY TECHNIQUE

7.1 Overview by Technique
7.2 Historical and Forecast Data
7.3 Analysis by Technique
7.4 Molecular Assay Historic and Forecast Sales by Regions
7.5 Sequenced-Based Molecular Assay Historic and Forecast Sales by Regions
7.6 Non-Molecular Assay Historic and Forecast Sales by Regions

8 . GLOBAL HLA TYPING MARKET ANALYSIS BY END-USER

8.1 Overview by End-User
8.2 Historical and Forecast Data
8.3 Analysis by End-User
8.4 Commercial Service Providers Historic and Forecast Sales by Regions
8.5 Hospitals And Transplant Centers Historic and Forecast Sales by Regions
8.6 Research Labs & Academic Institutes Historic and Forecast Sales by Regions

9 . GLOBAL HLA TYPING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HLA TYPING COMPANIES

10.1. Hla Typing Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF HLA TYPING INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Thermo Fisher Scientific Inc.
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Bio-Rad Laboratories Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Qiagen N.V.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Omixon Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. GenDx
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Illumina Inc.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. TBG Diagnostics Limited
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Dickinson and Company
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Takara Bio Inc.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. F. Hoffman-La Roche Limited
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Pacific Biosciences
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments